NASDAQ:AKBA

Akebia Therapeutics Stock News

etoro logo Buy AKBA
*Your capital is at risk
$0.97
+0.0333 (+3.56%)
At Close: Jun 03, 2026
Insiders are buying these penny stocks but are they worth the risk? The post 3 Top Penny Stocks To Buy According To Insiders Before 2023 appeared first on Penny Stocks to Buy, Picks, News and Informat
Penny stocks to watch trading under $1 right now. The post Penny Stocks To Buy Now?

7 Hot Penny Stocks Under $1 To Watch This Week

07:51pm, Monday, 12'th Dec 2022 PennyStocks
Penny stocks to watch trading under $1 right now. The post 7 Hot Penny Stocks Under $1 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

7 Hot Penny Stocks Under $1 To Watch This Week

02:51pm, Monday, 12'th Dec 2022
Penny stocks to watch trading under $1 right now. The post 7 Hot Penny Stocks Under $1 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

10 Top Penny Stocks To Watch Under $1 This Week

07:11pm, Wednesday, 07'th Dec 2022 PennyStocks
Penny stocks under $1 to watch this week. The post 10 Top Penny Stocks To Watch Under $1 This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of -86.67% and 3.80%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock
Akebia Therapeutics, Inc. (NASDAQ:AKBA ) Q3 2022 Results Conference Call November 3, 2022 4:30 PM ET Company Participants Mercedes Carrasco - Senior Director of Corporate Communications John Butler -
Gainers M-tron Industries, Inc. (NASDAQ: MPTI) rose 57.9% to $24.00 in pre-market trading after surging 10% on Friday. M-tron Industries completed its earlier announced separation from The LGL Group,
Gainers 9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 31.4% to $0.2720 in pre-market trading after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA f
Akebia Therapeutics Inc. (NASDAQ:AKBA ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Mercedes Carrasco - Senior Director of Corporate Communications John Butler - CE

Akebia Therapeutics (AKBA) Surpasses Q2 Earnings and Revenue Estimates

11:25pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of 174.19% and 158.19%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of 174.19% and 158.19%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Gainers Getty Images Holdings, Inc. (NYSE: GETY) rose 104.5% to $21.47 in pre-market trading. ThermoGenesis Holdings, Inc. (NASDAQ: THMO) rose 34.3% to $0.2850 in pre-market trading after gaining ove

Hot Penny Stocks to Buy Now? 3 to Watch in Early July 

09:23pm, Wednesday, 06'th Jul 2022 PennyStocks
Check these penny stocks out for your watchlist The post Hot Penny Stocks to Buy Now? 3 to Watch in Early July  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Check these penny stocks out for your watchlist The post Hot Penny Stocks to Buy Now? 3 to Watch in Early July  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE